Approval · Notice of Compliance 9425 · 2008
RETISERT: Notice of Compliance 9425
Issued March 13, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9425
- Date
- March 13, 2008
- Company
- Bausch & Lomb Inc.Rochester, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RETISERT | 02306980 | Dormant |
Medicinal ingredients
- FLUOCINOLONE ACETONIDE 0.59 MG per IMP